|
Quotes & Info
|
| PSYS > SEC Filings for PSYS > Form 8-K on 8-May-2009 | All Recent SEC Filings |
8-May-2009
Entry into a Material Definitive Agreement, Financial Statements and Ex
determined by the Company to be required to be redeemed to prevent such Note
from being treated as an "applicable high yield discount obligation" within the
meaning of Section 163(i)(1) of the Code. The redemption price for the portion
of each Note redeemed will be 100% of the principal amount of such portion plus
any accrued interest thereon on the date of redemption.
The Company may redeem the Notes, in whole at any time or in part from time
to time, (i) prior to July 15, 2010, at a redemption price equal to 100% of the
principal amount thereof plus a make-whole premium, (ii) during the twelve-month
periods beginning on July 15 of the years 2010, 2011, and 2012, at redemption
prices equal to 103.875%, 102.583% and 101.292%, respectively, of the principal
amount thereof, and (iii) on and after July 15, 2013, at a redemption price
equal to 100% of the principal amount thereof, in each case, plus any accrued
and unpaid interest to the redemption date.
The Indenture contains events of default (subject in certain cases to
customary grace and cure periods), including, among other things, payment
defaults, material inaccuracies of representations and warranties, breach of
covenants, cross-defaults to other indebtedness, and bankruptcy and insolvency
defaults. A default under the Indenture would permit the Trustee and/or the
holders of at least 25% in principal amount of the outstanding Notes to require
immediate repayment of all principal together with all accrued and unpaid
interest on the Notes.
The description of the Indenture set forth above does not purport to be
complete and is subject to and qualified in its entirety by reference to the
text of the Indenture, a copy of which is included as Exhibit 4.2 hereto and
incorporated herein by reference.
In connection with the closing of the sale of the Notes, the Company and its
subsidiaries that guarantee the Notes pursuant to the Indenture entered into a
Registration Rights Agreement, dated as of May 7, 2009 (the "Registration Rights
Agreement"), whereby the Company agreed, under certain circumstances, to
register notes with substantially identical terms to the Notes (the "Registered
Notes") and commence an exchange offer to allow holders of the Notes to exchange
their Notes for Registered Notes. However, the Company will not be required to
make the exchange offer to the extent the Notes are freely tradable under
Rule 144 under the Securities Act, the restrictive legend has been removed from
the Notes and the Notes do not bear a restricted CUSIP number. The description
of the Registration Rights Agreement set forth herein does not purport to be
complete and is subject to and qualified in its entirety by reference to the
text of the Registration Rights Agreement, a copy of which is included as
Exhibit 4.4 hereto and incorporated herein by reference.
Proceeds from the issuance of the Notes were used to pay a portion of the
outstanding balance under the Company's revolving credit facility and pay
related fees and expenses.
The Initial Purchasers and certain of their affiliates have provided and may
in the future provide financial advisory, investment banking and commercial
banking services in the ordinary course of business to the Company and its
guarantor subsidiaries and certain of their affiliates, for which they receive
customary fees and expense reimbursement. Banc of America and Citigroup acted as
joint lead arrangers and joint book managers for the Company's senior secured
revolving credit facility, and Bank of America, N.A., an affiliate of Banc of
America, serves as administrative agent, collateral agent and a lender under the
Company's senior secured revolving credit facility. Citigroup acted as sole lead
arranger and sole book manager for the
Company's senior secured term loan facility, and Citicorp North America, Inc.,
an affiliate of Citigroup, serves as administrative agent under the Company's
senior secured term loan facility. Certain of the other initial purchasers (or
affiliates thereof) are lenders and/or agents or arrangers under our senior
secured credit facilities. In addition, CIT Capital Securities LLC and Fifth
Third Bank (or one of its affiliates), each of which are a lender or an
affiliate of a lender under the Company's senior secured credit facilities,
acted as financial advisors to the Company in connection with the offering of
the Notes and received a reasonable advisory fee in connection therewith.
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an
Off-Balance Sheet Arrangement of a Registrant.
The information provided under Item 1.01 is incorporated herein by reference.
4.2 Indenture, dated as of May 7, 2009, among Psychiatric Solutions, Inc., the subsidiaries of Psychiatric Solutions, Inc. party thereto as guarantors and U.S. Bank National Association, as Trustee.
4.3 Form of Notes (included in Exhibit 4.2).
4.4 Registration Rights Agreement, dated as of May 7, 2009, among Psychiatric Solutions, Inc., the subsidiaries of Psychiatric Solutions, Inc. party thereto as guarantors, and Banc of America Securities LLC, Barclays Capital Inc., Citigroup Global Markets Inc., J.P. Morgan Securities Inc. and RBC Capital Markets Corporation.
|
|